BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 51 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,744 | -10.1% | 11,855,000 | -8.7% | 0.03% | -6.7% |
| Q2 2023 | $13,059 | -23.0% | 12,990,000 | -20.1% | 0.03% | -26.8% |
| Q1 2023 | $16,949 | -1.1% | 16,250,000 | +1.9% | 0.04% | -6.8% |
| Q4 2022 | $17,139 | -99.9% | 15,950,000 | 0.0% | 0.04% | +2.3% |
| Q3 2022 | $15,840,000 | +7.0% | 15,950,000 | +7.0% | 0.04% | +10.3% |
| Q2 2022 | $14,807,000 | -9.8% | 14,900,000 | -9.1% | 0.04% | +21.9% |
| Q1 2022 | $16,421,000 | -11.1% | 16,400,000 | -7.3% | 0.03% | -11.1% |
| Q4 2021 | $18,463,000 | +15.3% | 17,700,000 | +10.6% | 0.04% | +9.1% |
| Q3 2021 | $16,013,000 | – | 16,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT CAPITAL MANAGEMENT /DE/ | 70,652,000 | $71,212,000 | 1.38% |
| SHENKMAN CAPITAL MANAGEMENT INC | 14,821,000 | $14,947,000 | 1.36% |
| AQR Arbitrage LLC | 21,650,000 | $21,800,000 | 0.61% |
| Worth Venture Partners, LLC | 708,000 | $714,000 | 0.27% |
| LOOMIS SAYLES & CO L P | 2,366,716 | $197,478,000 | 0.24% |
| MACKAY SHIELDS LLC | 24,500,000 | $24,670,000 | 0.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 2,500,000 | $2,505,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,429,000 | $2,442,000 | 0.06% |
| Alberta Investment Management Corp | 5,500,000 | $5,545,000 | 0.05% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,900,000 | $1,913,000 | 0.04% |